About
Sigilon Therapeutics’ mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases.
- Website
- Headquarters
- Industries
- Employees51-200
- Social
Photos
Add photos to showcase Sigilon Therapeutics’s culture
Values
Add Sigilon Therapeutics’s values
Insider experiences
Share your experience of working at Sigilon Therapeutics
Org chart
View org chartRogerio Vivaldi Coelho
President and CEO
Collapse
Matthew Kowalsky
Chief Legal Officer
Philip Ashton-Rickardt
Chief Scientific Officer
Josias Pontes
VP, Head of Finance
Susan Drapeau
VP, Head of Device and Delivery Engineering
Robert Windsor Jr.
VP, Head of Investor Relations
Jiang Wu
VP, Head of Bioanalytical & CMC Analytical Development
Bernd Kullmann
VP, Head of Manufacturing & Supply Chain
Ajay Rai
SVP, Head of Business Development
Olivia G. Kelly
VP, Head of Islet Cell Therapy Research
Teams
View all (0)Add your teams to show how people work together at Sigilon Therapeutics
Jobs
View all (0)Add jobs to your org chart to show candidates who they’ll work with
Wires
View all (0)Publish company announcements to get more exposure